COVID-19 Update 
Where patients, partners, and quality matter
For over 75 years, Lannett has been proudly providing high-quality, affordable generic pharmaceutical products to patients who depend on them.
What product are you looking for?
Patient Support
We manufacture over 100 unique pharmaceutical product families for a wide range of therapeutic areas, with many more in development. Our philosophy? Patients first.
Our Approach
Many of our patients will never know they are taking one of our medicines. But we know. That’s why we strive for the highest quality standards in our pharmaceutical products.
Careers
Our culture combines a legacy of quality with an appetite for innovation. We’re looking for motivated, engaged individuals to help make the medicines that save and enhance lives.
Spotlight
August 3, 2020
Lannett Announces Launch Of FDA Approved Levothyroxine Tablets
Lannett Company, Inc. (NYSE: LCI) today announced the launch of Cediprof, Inc.’s FDA approved Levothyroxine Sodium Tablets USP, under the companies’ recently announced interim exclusive supply and distribution agreement. The companies also said they have prevailed in separate legal challenges by Cediprof’s previous distributor of the product. Judges in two courts denied a request by the previous distribution partner for a temporary restraining order that sought to enjoin Cediprof from terminating the prior agreement and transferring distribution rights to Lannett.